Cargando…

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

Detalles Bibliográficos
Autores principales:	Siddiqi, Hasan K., Mehra, Mandeep R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ished by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118652/ https://www.ncbi.nlm.nih.gov/pubmed/32362390 http://dx.doi.org/10.1016/j.healun.2020.03.012

Ejemplares similares

COVID-19 Illness and Heart Failure: A Missing Link?
por: Mehra, Mandeep R., et al.
Publicado: (2020)

Early Immunosuppression and Rapid Recovery of Cardiogenic Shock in Multisystem Inflammatory Syndrome From Convalescent COVID-19
por: Coll, Maxwell D., et al.
Publicado: (2021)

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh
por: Hasan, Md Jahidul, et al.
Publicado: (2022)

Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients
por: M, Montero-Baladía, et al.
Publicado: (2020)

COVID-19: Yet another coronavirus challenge in transplantation
por: Aslam, Saima, et al.
Publicado: (2020)

A proposal for staging COVID‐19 coagulopathy
por: Thachil, Jecko, et al.
Publicado: (2020)

Critically Ill Immunosuppressed Host
por: Masur, Henry
Publicado: (2008)

Dilemma of organ donation in transplantation and the COVID-19 pandemic
por: Woolley, Ann E., et al.
Publicado: (2020)

Is therapeutic hypothermia immunosuppressive?
por: Polderman, Kees H
Publicado: (2012)

COVID-19 vaccination immune paresis in heart and lung transplantation
por: Aslam, Saima, et al.
Publicado: (2021)

The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID‐19 infection
por: Goto, Kohsaku, et al.
Publicado: (2021)

COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients
por: Luglio, Michele, et al.
Publicado: (2020)

Special Article - Palliative care considerations for cardiovascular clinicians in COVID-19
por: Desai, Akshay S., et al.
Publicado: (2020)

672 Native American gravidas are more likely to develop severe COVID-19 illness than non-Native American women
por: Quiner, Trevor, et al.
Publicado: (2021)

From asymptomatic to critical illness: decoding various clinical stages of COVID-19
por: ÇELİK, İlhami, et al.
Publicado: (2021)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

COVID-19 in Immunosuppressed Children
por: Nicastro, Emanuele, et al.
Publicado: (2021)

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
por: Atri, Deepak, et al.
Publicado: (2020)

Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants
por: Ezeokoli, Obinna T., et al.
Publicado: (2021)

Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States
por: Patel, Manish, et al.
Publicado: (2020)

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

Immunosuppressive peptides and their therapeutic applications()
por: Thell, Kathrin, et al.
Publicado: (2014)

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: Mehra, Mandeep R, et al.
Publicado: (2020)

STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
por: Siddiqi, Hasan, et al.
Publicado: (2021)

Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients
por: Spinetti, Thibaud, et al.
Publicado: (2020)

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
por: Kenny, Grace, et al.
Publicado: (2023)

Immunosuppressants: COVID-19: case report
Publicado: (2020)

Evolving evidence for immunosuppressants in COVID-19
Publicado: (2021)

Therapeutic strategies for critically ill patients with COVID-19
por: Li, Lei, et al.
Publicado: (2020)

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19
por: Esam, Zohreh
Publicado: (2020)

COVID-19 – A vascular disease
por: Siddiqi, Hasan K., et al.
Publicado: (2021)

Strongyloides hyperinfection syndrome precipitated by immunosuppressive therapy for rheumatoid arthritis and COVID-19 pneumonia
por: Hamze, Hasan, et al.
Publicado: (2023)

Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities
por: Wang, Lu, et al.
Publicado: (2020)

Clinical course of COVID-19 disease in immunosuppressed renal transplant patients
por: DHEİR¹, Hamad, et al.
Publicado: (2021)

Adhesive capsulitis: MRI correlation with clinical stages and proposal of MRI staging
por: Chellathurai, Amarnath, et al.
Publicado: (2019)

Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015
por: Singh, Tajinder P., et al.
Publicado: (2020)

COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
por: Siddiqi, Hasan K., et al.
Publicado: (2020)

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: Mehra, Mandeep R, et al.
Publicado: (2020)

Native Voices Exhibition: Stories of health, wellness, and illness from American Indians, Alaska Natives, and Native Hawaiians
por: Wood, Frederick B., et al.
Publicado: (2022)

The Comparison of Parameters of Oxidative Stress in Native Rat Livers Between Different Immunosuppressive Regimens
por: Wilk, Aleksandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nqcmr0j2kgk8r43bghm1igjpjl